[HTML][HTML] Neprilysin and Aβ clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease

MOW Grimm, J Mett, CP Stahlmann… - Frontiers in aging …, 2013 - frontiersin.org
One of the characteristic hallmarks of Alzheimer's disease (AD) is an accumulation of
amyloid β (Aβ) leading to plaque formation and toxic oligomeric Aβ complexes. Besides the …

Long-term neprilysin inhibition—implications for ARNIs

DJ Campbell - Nature Reviews Cardiology, 2017 - nature.com
Neprilysin has a major role in both the generation and degradation of bioactive peptides.
LCZ696 (valsartan/sacubitril, Entresto), the first of the new ARNI (dual-acting angiotensin …

[HTML][HTML] Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling

E Kim, H Kim, MP Jedrychowski, G Bakiasi, J Park… - Neuron, 2023 - cell.com
A pathological hallmark of Alzheimer's disease (AD) is the deposition of amyloid-β (Aβ)
protein in the brain. Physical exercise has been shown to reduce Aβ burden in various AD …

[HTML][HTML] Silver nanoparticles affect on gene expression of inflammatory and neurodegenerative responses in mouse brain neural cells

CL Huang, IL Hsiao, HC Lin, CF Wang, YJ Huang… - Environmental …, 2015 - Elsevier
Silver nanoparticles (AgNPs) have antibacterial characteristics, and currently are applied in
Ag-containing products. This study found neural cells can uptake 3–5 nm AgNPs, and …

Alzheimer's disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines

D Zádori, G Veres, L Szalárdy… - Journal of Alzheimer's …, 2018 - content.iospress.com
The pathomechanism of Alzheimer's disease (AD) certainly involves mitochondrial
disturbances, glutamate excitotoxicity, and neuroinflammation. The three main aspects of …

[HTML][HTML] Advances in amyloid-β clearance in the brain and periphery: implications for neurodegenerative diseases

R Ullah, EJ Lee - Experimental Neurobiology, 2023 - ncbi.nlm.nih.gov
This review examines the role of impaired amyloid-β clearance in the accumulation of
amyloid-β in the brain and the periphery, which is closely associated with Alzheimer's …

Formaldehyde, epigenetics, and Alzheimer's disease

F Wang, D Chen, P Wu, C Klein… - Chemical research in …, 2019 - ACS Publications
Alzheimer's disease (AD) is the most common form of dementia. The accumulation of β-
amyloid plaques and intracellular neurofibrillary tangles of hyperphosphorylated tau protein …

Pharmacogenomics of Alzheimer's disease: Novel therapeutic strategies for drug development

R Cacabelos, P Cacabelos, C Torrellas… - … in Drug Discovery and …, 2014 - Springer
Alzheimer's disease (AD) is a major problem of health and disability, with a relevant
economic impact on our society. Despite important advances in pathogenesis, diagnosis …

Impact of insulin degrading enzyme and neprilysin in Alzheimer's disease biology: characterization of putative cognates for therapeutic applications

NK Jha, SK Jha, D Kumar, N Kejriwal… - Journal of …, 2015 - content.iospress.com
Alzheimer's disease (AD) is a neurodegenerative process primarily characterized by
amyloid-β (Aβ) agglomeration, neuroinflammation, and cognitive dysfunction. The prominent …

[HTML][HTML] All roads lead to Rome—a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer's disease

YY Liang, LD Zhang, X Luo, LL Wu… - Neural regeneration …, 2022 - journals.lww.com
Age-related neurodegenerative disorders such as Alzheimer's disease (AD) have become a
critical public health issue due to the significantly extended human lifespan, leading to …